6 Patents
- US122408402025Amide-substituted Heterocyclic Compounds for the Treatment of Conditions Related to the Modulation of IL-12, IL-23 And/or Ifn-alpha
Bristol-myers Squibb Company
0 cites - 0 cites
- 0 cites
- 0 cites
- 0 cites
- 0 cites
Bristol-myers Squibb Company